skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
First records of the West African torpedo in Cabo Verde Archipelago, eastern Atlantic
Material Type:
Article
Add to My Research

First records of the West African torpedo in Cabo Verde Archipelago, eastern Atlantic

Oryx, 2022-03, Vol.56 (2), p.172-173 [Peer Reviewed Journal]

Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of Fauna & Flora International ;Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of Fauna & Flora International. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0030-6053 ;EISSN: 1365-3008 ;DOI: 10.1017/S0030605321001836

Full text available

2
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Material Type:
Article
Add to My Research

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

npj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518

Full text available

3
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Material Type:
Article
Add to My Research

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

Cell, 2020-11, Vol.183 (5), p.1367-1382.e17 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.10.043 ;PMID: 33160446

Digital Resources/Online E-Resources

4
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article
Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Cell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077

Full text available

5
Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains
Material Type:
Article
Add to My Research

Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains

Proceedings of the National Academy of Sciences - PNAS, 2023-03, Vol.120 (11), p.e2214556120-e2214556120 [Peer Reviewed Journal]

Copyright National Academy of Sciences Mar 14, 2023 ;Copyright © 2023 the Author(s). Published by PNAS. 2023 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2214556120 ;PMID: 36888664

Full text available

6
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Material Type:
Article
Add to My Research

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199

Full text available

7
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens
Material Type:
Article
Add to My Research

Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens

Cell reports. Medicine, 2022-10, Vol.3 (10), p.100780, Article 100780 [Peer Reviewed Journal]

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100780 ;PMID: 36206752

Full text available

8
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article
Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

bioRxiv, 2021-03

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.03.15.435528

Digital Resources/Online E-Resources

9
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Material Type:
Article
Add to My Research

Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates

bioRxiv, 2021-02

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.02.10.430696v1 ;DOI: 10.1101/2021.02.10.430696

Digital Resources/Online E-Resources

10
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
Material Type:
Article
Add to My Research

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2

bioRxiv, 2020-08

2020. This article is published under http://creativecommons.org/licenses/by-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2020.08.11.247395

Digital Resources/Online E-Resources

11
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
Material Type:
Article
Add to My Research

Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples

bioRxiv, 2021-07

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.07.02.450915

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (7)

Searching Remote Databases, Please Wait